These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 39133476)
1. Perioperative Management of Patients Taking Direct Oral Anticoagulants: A Review. Douketis JD; Spyropoulos AC JAMA; 2024 Sep; 332(10):825-834. PubMed ID: 39133476 [TBL] [Abstract][Full Text] [Related]
2. Managing the perioperative patient on direct oral anticoagulants. Leitch J; van Vlymen J Can J Anaesth; 2017 Jun; 64(6):656-672. PubMed ID: 28429198 [TBL] [Abstract][Full Text] [Related]
3. A Survey of Direct Oral Anticoagulant Cessation in General Surgery and Outcomes in Patients with Nonvalvular Atrial Fibrillation. Kawabata M; Goya M; Maeda S; Yagishita A; Takahashi Y; Sasano T; Hirao K Int Heart J; 2020 Sep; 61(5):905-912. PubMed ID: 32921660 [TBL] [Abstract][Full Text] [Related]
4. Predictors of Bleeding in the Perioperative Anticoagulant Use for Surgery Evaluation Study. Tafur AJ; Clark NP; Spyropoulos AC; Li N; Kaplovitch E; MacDougall K; Schulman S; Caprini JA; Douketis J J Am Heart Assoc; 2020 Oct; 9(19):e017316. PubMed ID: 32969288 [TBL] [Abstract][Full Text] [Related]
5. [Analysis of the Risk Factors Associated with Minor Bleeding in Patients with Venous Thromboembolism during Treatment with Direct Oral Anticoagulants]. Sunaga T; Shimizu T; Nakamura S; Takahashi N; Higashino M; Matsui M; Hozumi T; Ebato M; Suzuki H; Kogo M; Watanabe T; Sasaki T Yakugaku Zasshi; 2019; 139(3):461-467. PubMed ID: 30828024 [TBL] [Abstract][Full Text] [Related]
6. Comparative study of hemorrhagic and ischemic complications among anticoagulants in patients undergoing cryoballoon ablation for atrial fibrillation. Okishige K; Nakamura T; Aoyagi H; Kawaguchi N; Yamashita M; Kurabayashi M; Suzuki H; Asano M; Shimura T; Yamauchi Y; Sasano T; Hirao K J Cardiol; 2017 Jan; 69(1):11-15. PubMed ID: 27160710 [TBL] [Abstract][Full Text] [Related]
7. Thrombotic complications with interruption of direct oral anticoagulants in dermatologic surgery. Siscos SM; Neill BC; Singh AH; Hocker TLH J Am Acad Dermatol; 2021 Feb; 84(2):425-431. PubMed ID: 33045293 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the Safety and Effectiveness of Four Direct Oral Anticoagulants in Japanese Patients with Nonvalvular Atrial Fibrillation Using Real-World Data. Enomoto A; Mano Y; Kawano Y; Nishikawa T; Aoyama T; Sasaki Y; Nagata M; Takahashi H Biol Pharm Bull; 2021; 44(9):1294-1302. PubMed ID: 34471057 [TBL] [Abstract][Full Text] [Related]
9. Jurisdictional Guidance on DOAC Use-Will It Affect Practice? A Comparison of European, American, and Canadian Product Monographs. Lamb DA; Bungard TJ; Lowerison J; Semchuk WM; Thomson P; Brocklebank C; Bolt J Ann Pharmacother; 2020 Mar; 54(3):277-282. PubMed ID: 31529984 [No Abstract] [Full Text] [Related]
10. An update on the bleeding risks associated with DOACs. Drug Ther Bull; 2017 Nov; 55(11):129-132. PubMed ID: 29117993 [TBL] [Abstract][Full Text] [Related]
11. A review of oral anticoagulants, old and new, in major bleeding and the need for urgent surgery. Milling TJ; Ziebell CM Trends Cardiovasc Med; 2020 Feb; 30(2):86-90. PubMed ID: 30952383 [TBL] [Abstract][Full Text] [Related]
12. Update on Direct Oral AntiCoagulants (DOACs). Koscielny J; Rosenthal C; von Heymann C Hamostaseologie; 2017; 37(4):267-275. PubMed ID: 29582929 [TBL] [Abstract][Full Text] [Related]
13. Thrombotic and bleeding outcomes following perioperative interruption of direct oral anticoagulants in patients with venous thromboembolic disease. Shaw J; de Wit C; Le Gal G; Carrier M J Thromb Haemost; 2017 May; 15(5):925-930. PubMed ID: 28296069 [TBL] [Abstract][Full Text] [Related]
14. Bleeding Risk of Add-On Anti-Platelet Agents to Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation (From 2216 Patients in the DIRECT Registry). Sotomi Y; Hirata A; Amiya R; Kobayashi T; Hirayama A; Sakata Y; Higuchi Y Am J Cardiol; 2019 Apr; 123(8):1293-1300. PubMed ID: 30717887 [TBL] [Abstract][Full Text] [Related]
15. Anticoagulation in Patients with Chronic Kidney Disease. Elenjickal EJ; Travlos CK; Marques P; Mavrakanas TA Am J Nephrol; 2024; 55(2):146-164. PubMed ID: 38035566 [TBL] [Abstract][Full Text] [Related]
16. Idarucizumab and factor Xa reversal agents: role in hospital guidelines and protocols. Huisman MV; Fanikos J Am J Emerg Med; 2016 Nov; 34(11S):46-51. PubMed ID: 27697438 [TBL] [Abstract][Full Text] [Related]
17. A systematic review and Bayesian network meta-analysis of risk of intracranial hemorrhage with direct oral anticoagulants. Wolfe Z; Khan SU; Nasir F; Raghu Subramanian C; Lash B J Thromb Haemost; 2018 Jul; 16(7):1296-1306. PubMed ID: 29723935 [TBL] [Abstract][Full Text] [Related]
18. Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience. Eikelboom J; Merli G Am J Med; 2016 Nov; 129(11S):S33-S40. PubMed ID: 27586367 [TBL] [Abstract][Full Text] [Related]